$HLYK·8-K

HealthLynked Corp · Jul 16, 4:02 PM ET

Compare

HealthLynked Corp 8-K

Research Summary

AI-generated summary

Updated

HealthLynked Corp Appoints Interim CFO; Eliminates COO Role

What Happened

  • HealthLynked Corp filed an 8-K (Item 5.02) reporting executive changes. Effective July 13, 2026, the company appointed George O’Leary (age 63) as part‑time Interim Chief Financial Officer. Jeremy Daniel ceased serving as CFO on July 13, 2026 and transitioned to a corporate accounting role; the company states this transition was not due to any disagreement with management or the board. Effective July 24, 2026, HealthLynked will eliminate the Chief Operating Officer position; Duncan McGillivray will cease serving as COO and will continue with the company under an Independent Consulting Agreement as a Senior Strategic Advisor on an as‑needed basis.

Key Details

  • Mr. O’Leary will work three days per week as Interim CFO for $15,000 per month.
  • The company issued Mr. O’Leary 35,000 stock options at a $3.50 exercise price that vest upon the company’s successful approval for listing on the Nasdaq Capital Market while he is serving (or during a 30‑day notice period following termination).
  • Mr. O’Leary has been a HealthLynked director since August 6, 2014 and previously served as the company’s CFO from August 6, 2014 to April 4, 2024; his recent roles include CEO of Sono Group NV (Apr 2024–Dec 2025).
  • The filing notes there were no disagreements with management or the board in connection with Mr. Daniel’s transition; no related‑party transactions or family relationships requiring disclosure were reported for Mr. O’Leary.

Why It Matters

  • These changes affect the company’s finance and operations leadership: an experienced former CFO and current director is stepping in as an interim, part‑time CFO with compensation and option incentives tied to a Nasdaq listing, which is material for investors tracking corporate governance and capital‑markets plans. The elimination of the COO role and the move of that executive to a consulting advisor role also signals a change in executive structure and potential cost/management alignment. Investors should note the concrete terms (pay, option grant, vesting condition) and the stated absence of any disagreement related to the CFO transition.

Loading document...